Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Hogwood

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2014
Chromatographic molecular weight measurements for heparin, its fragments and fractions, and other glycosaminoglycansBarbara Mulloy, John Hogwood
Handbook of Experimental Pharmacology|March 31, 2026
Haemostasis and the Need for Antithrombotics: An IntroductionJohn Hogwood, Elaine Gray
Handbook of Experimental Pharmacology|December 30, 2025
Heparin: Over 100 Years of AnticoagulationJohn Hogwood, Elaine Gray
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2021
Chromatographic Molecular Weight Measurements for Heparin , Its Fragments and Fractions, and Other GlycosaminoglycansBarbara Mulloy, John Hogwood
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Heparin, Heparan Sulphate and Sepsis: Potential New Options for TreatmentJohn Hogwood, Elaine Gray, Barbara Mulloy
Pharmaceuticals (Basel, Switzerland)|July 4, 2017
Precipitation and Neutralization of Heparin from Different Sources by Protamine SulfateJohn Hogwood, Barbara Mulloy, Elaine Gray
Handbook of Experimental Pharmacology|May 9, 2012
The anticoagulant and antithrombotic mechanisms of heparinElaine Gray, John Hogwood, Barbara Mulloy
Journal of Thrombosis and Haemostasis : JTH|August 29, 2019
A new WHO reference reagent for activated blood coagulation factor X (FXa), human (15/102)Craig Thelwell, John Hogwood, Sarah Daniels, et al.
Plos One|May 30, 2020
Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole bloodJohn Hogwood, Simon Pitchford, Barbara Mulloy, et al.
Pharmacological Reviews|December 17, 2015
Pharmacology of Heparin and Related DrugsBarbara Mulloy, John Hogwood, Elaine Gray, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|October 19, 2014
Chromatographic molecular weight measurements for heparin, its fragments and fractions, and other glycosaminoglycansBarbara Mulloy, John Hogwood
Handbook of Experimental Pharmacology|March 31, 2026
Haemostasis and the Need for Antithrombotics: An IntroductionJohn Hogwood, Elaine Gray
Handbook of Experimental Pharmacology|December 30, 2025
Heparin: Over 100 Years of AnticoagulationJohn Hogwood, Elaine Gray
Methods in Molecular Biology (Clifton, N.J.)|October 9, 2021
Chromatographic Molecular Weight Measurements for Heparin , Its Fragments and Fractions, and Other GlycosaminoglycansBarbara Mulloy, John Hogwood
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Heparin, Heparan Sulphate and Sepsis: Potential New Options for TreatmentJohn Hogwood, Elaine Gray, Barbara Mulloy
Pharmaceuticals (Basel, Switzerland)|July 4, 2017
Precipitation and Neutralization of Heparin from Different Sources by Protamine SulfateJohn Hogwood, Barbara Mulloy, Elaine Gray
Handbook of Experimental Pharmacology|May 9, 2012
The anticoagulant and antithrombotic mechanisms of heparinElaine Gray, John Hogwood, Barbara Mulloy
Journal of Thrombosis and Haemostasis : JTH|August 29, 2019
A new WHO reference reagent for activated blood coagulation factor X (FXa), human (15/102)Craig Thelwell, John Hogwood, Sarah Daniels, et al.
Plos One|May 30, 2020
Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole bloodJohn Hogwood, Simon Pitchford, Barbara Mulloy, et al.
Pharmacological Reviews|December 17, 2015
Pharmacology of Heparin and Related DrugsBarbara Mulloy, John Hogwood, Elaine Gray, et al.
Pageof 3